Anti-HER2 Antibody

<strong>Anti-HER2 Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2014847_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 20 uL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> ERBB2_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Hosseini Ghatar R, Soltantoyeh T, Bahadori M, Khoshnoodi J, Golsaz Shirazi F, Jeddi Tehrani M, Amiri MM, Shokri F. Polyclonal Antibody against Different Extracellular Subdomains of HER2 Induces Tumor Growth Inhibition in vitro Iran J Immunol. 2017 Sep;14(3):200-214._x000D_ 2: Jurianz K, Maslak S, Garcia-Schüler H, Fishelson Z, Kirschfink M. Neutralization of complement regulatory proteins augments lysis of breast carcinoma cells targeted with rhumAb anti-HER2 Immunopharmacology. 1999 May;42(1-3):209-18._x000D_ 3: Xu Y, Wang Y, Gong J, Zhang X, Peng Z, Sheng X, Mao C, Fan Q, Bai Y, Ba Y, Jiang D, Yang F, Qi C, Li J, Wang X, Zhou J, Lu M, Cao Y, Yuan J, Liu D, Wang Z, Fang J, Shen L. Phase I study of the recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors Gastric Cancer. 2021 Jul;24(4):913-925._x000D_ 4: Takei J, Asano T, Tanaka T, Sano M, Hosono H, Nanamiya R, Tateyama N, Saito M, Suzuki H, Harada H, Kaneko MK, Kato Y. Development of a Novel Anti-HER2 Monoclonal Antibody H(2)Mab-181 for Gastric Cancer Monoclon Antib Immunodiagn Immunother. 2021 Aug;40(4):168-176._x000D_ 5: Asano T, Takei J, Suzuki H, Kaneko MK, Kato Y. Epitope Mapping of an Anti-HER2 Monoclonal Antibody (H(2)Mab-181) Using Enzyme-Linked Immunosorbent Assay Monoclon Antib Immunodiagn Immunother. 2021 Dec;40(6):255-260._x000D_ 6: Amiri MM, Golsaz-Shirazi F, Soltantoyeh T, Hosseini-Ghatar R, Bahadori T, Khoshnoodi J, Navabi SS, Farid S, Karimi-Jafari MH, Jeddi-Tehrani M, Shokri F. Hersintuzumab: A novel humanized anti-HER2 monoclonal antibody induces potent tumor growth inhibition Invest New Drugs. 2018 Apr;36(2):171-186._x000D_ 7: Zeng J, Zhang H, Guan R. Bioactivity of recombinant humanized monoclonal antibody against HER2 in-vivo and in-vitro and its mechanism of action in ovarian cancer Transl Cancer Res. 2023 Jun 30;12(6):1565-1576._x000D_ 8: Dank M. [Human recombinant anti-HER2 monoclonal antibody--a new targeted treatment in breast cancer] Orv Hetil. 2001 Nov 18;142(46):2563-8._x000D_ 9: Ramezani-Aliakbari K, Khaki-Bakhtiarvand V, Mahmoudian J, Asgarian-Omran H, Shokri F, Hojjat-Farsangi M, Jeddi-Tehrani M, Shabani M. Evaluation of the anti-tumor effects of an anti-Human Epidermal growth factor receptor 2 (HER2) monoclonal antibody in combination with CD11b(+)/Gr-1(+) myeloid cells depletion using a recombinant peptibody in 4 T1-HER2 tumor model Int Immunopharmacol. 2023 Aug;121:110463._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/35729189">10: Zhang H, Ye X, Wen J, Cai Z, Li Y, Zhang M, Shen L, Cai J. Anti-HER2 scFv-CCL19-IL7 recombinant protein inhibited gastric tumor growth in vivo Sci Rep. 2022 Jun 21;12(1):10461. </a>_x000D_ _x000D_ <strong>Products Related to Anti-HER2 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>